◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
Closely watched Pfizer lung cancer drug falls short in clinical trial
1sources
1articles
0velocity
+0%since first seen
20d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (1)
- Pfizer’s first new ADC from Seagen acquisition fails phase 3 NSCLC trial Fierce Biotech · 21d ago
Related trends
▲ Peaking
Business
Citi sends powerful sign to SpaceX investors
▲ Peaking
Business
Thousands of Xbox Players Demand an End to Layoffs, Studio Closures on Microsoft's Own Fan Feedback Website
▲ Peaking
Business
Olive Garden’s most beloved pasta promotion is back after 6-year hiatus
▲ Peaking
Business
SoftBank's Son says AI will need $5 trillion per year by 2040, dismisses bubble talk
▲ Peaking
Business
Goodbye, middle seat. United's new seating design offers extra space
▲ Peaking
Business